Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Green, A. R.
Cross, A. J.
and
Goodwin, G. M.
1995.
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”).
Psychopharmacology,
Vol. 119,
Issue. 3,
p.
247.
Nantel, A.J.
1996.
Human Toxicology.
p.
493.
HALL, WAYNE
1998.
Cannabis use and psychosis.
Drug and Alcohol Review,
Vol. 17,
Issue. 4,
p.
433.
Rajs, Jovan
and
Fugelstad, Anna
1999.
Marihuana and Medicine.
p.
683.
Sembhi, Sati
and
Lee, Joseph W.Y.
1999.
Cannabis Use in Psychotic Patients.
Australian & New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 4,
p.
529.
Sembhi, Sati
and
Lee, Joseph W.Y.
1999.
Cannabis use in psychotic patients.
Australian and New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 4,
p.
529.
Pryor, S.R.
2000.
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal.
Medical Hypotheses,
Vol. 55,
Issue. 6,
p.
494.
Núñez, L. A.
and
Gurpegui, M.
2002.
Cannabis‐induced psychosis: a cross‐sectional comparison with acute schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 105,
Issue. 3,
p.
173.
Degenhardt, Louisa
and
Hall, Wayne
2002.
Cannabis and psychosis.
Current Psychiatry Reports,
Vol. 4,
Issue. 3,
p.
191.
núñez domínguez, L.A.
2002.
Situación actual de la psicosis cannábica.
Trastornos Adictivos,
Vol. 4,
Issue. 3,
p.
151.
Degenhardt, Louisa
Hall, Wayne
and
Lynskey, Michael
2003.
Testing hypotheses about the relationship between cannabis use and psychosis.
Drug and Alcohol Dependence,
Vol. 71,
Issue. 1,
p.
37.
Chen, Chih-Ken
and
Murray, Robin M.
2004.
Neurodevelopment and Schizophrenia.
p.
248.
Leweke, F Markus
Gerth, Christoph W
and
Klosterk??tter, Joachim
2004.
Cannabis-Associated Psychosis.
CNS Drugs,
Vol. 18,
Issue. 13,
p.
895.
Hall, Wayne
and
Degenhardt, Louisa
2004.
Marijuana and Madness.
p.
89.
Semple, David M.
McIntosh, Andrew M.
and
Lawrie, Stephen M.
2005.
Cannabis as a risk factor for psychosis: systematic review.
Journal of Psychopharmacology,
Vol. 19,
Issue. 2,
p.
187.
O'Daly, Owen G.
Guillin, Olivier
Tsapakis, Eva-Maria
Martinez, Diana
Shergill, Sukhwinder S.
Murray, Robin M.
and
Buckley, Peter F.
2005.
Schizophrenia and Substance Abuse Co-Morbidity.
Journal of Dual Diagnosis,
Vol. 1,
Issue. 2,
p.
11.
van Nimwegen, L.
de Haan, L.
van Beveren, N.
van den Brink, W.
and
Linszen, D.
2005.
Adolescence, schizophrenia and drug abuse: a window of vulnerability.
Acta Psychiatrica Scandinavica,
Vol. 111,
Issue. s427,
p.
35.
Grech, Anton
Van Os, Jim
Jones, Peter B.
Lewis, Shon W.
and
Murray, Robin M.
2005.
Cannabis use and outcome of recent onset psychosis.
European Psychiatry,
Vol. 20,
Issue. 4,
p.
349.
Beny, Ahuva
Paz, Alona
and
Potasman, Israel
2006.
Psychiatric Problems in Returning Travelers: Features and Associations.
Journal of Travel Medicine,
Vol. 8,
Issue. 5,
p.
243.
D'Souza, Deepak Cyril
2007.
Integrating the Neurobiology of Schizophrenia.
Vol. 78,
Issue. ,
p.
289.
eLetters
No eLetters have been published for this article.